Please assess the completion status of the following clinical trial:

Trial Title: Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Insulin naive Type 2 diabetes~* Currently treated with OADs alone or combined with other treatment for at least 3 months~* BMI below 40 kg/m2 and body weight below 125 kg~* HbA1c greater than or equal to 8%~Exclusion Criteria:~* Inability to tolerate metformin or contradictions to its use~* Pregnant, breastfeeding or intention of becoming pregnant~* Allergy to any of the trial products~* Inability or unwillingness to perform SMBG

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).